PDX Pharma’s President/CEO, Dr. Wassana Yantasee, will serve as chair for session IV of the 2018 Nanomedicine and Drug Delivery Symposium, hosted in Portland, Oregon (September 21-23). PDX Pharmaceuticals, in collaboration with Oregon Health and Science University’s biomedical engineering department, will present two posters at the conference:
Nanoparticle-mediated co-delivery of taxane and siRNA to mirror the first line treatment of drug-resistant HER2-positive breast cancer
Development of a new radiation sensitizer for lung cancer by targeting EGFR and PLK1 pathways with nanoparticles
More information about the 2018 NANODDS can be found here.